Table I.
Top 10 DElncRNAs in CESC tissues compared with normal samples.
| lncRNA | Expression change | Log2 FC | P-value | FDR |
|---|---|---|---|---|
| EMX2OS | Downregulation | −6.54 | 2.93×10−20 | 3.19×10−18 |
| MAGI2-AS3 | Downregulation | −4.70 | 1.27×10−29 | 4.28×10−27 |
| MIR100HG | Downregulation | −4.36 | 6.34×10−16 | 4.17×10−14 |
| DIO3OS | Downregulation | −4.17 | 2.50×10−08 | 4.99×10−07 |
| DNM3OS | Downregulation | −3.91 | 3.65×10−15 | 2.16×10−13 |
| LINC01451 | Upregulation | 6.04 | 5.47×10−4 | 3.81×10−3 |
| FAM83A-AS1 | Upregulation | 6.28 | 6.38×10−4 | 4.32×10−3 |
| C5orf66-AS1 | Upregulation | 6.62 | 3.89×10−4 | 2.83×10−3 |
| AC245041.1 | Upregulation | 6.82 | 9.30×10−4 | 5.88×10−3 |
| AL049555.1 | Upregulation | 7.47 | 3.93×10−4 | 2.86×10−3 |
CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; DE, differentially expressed; FC, fold change; FDR, false discovery rate.